Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00014729
Status:
COMPLETED
Last Update Posted:
2015-03-25
First Post:
2001-04-10
Brief Title:
Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa
Sponsor:
University of North Carolina
Organization:
FDA Office of Orphan Products Development
Organization Data
Organization:
FDA Office of Orphan Products Development
Class:
FED
Study ID:
19915738
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of North Carolina
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None